Literature DB >> 15279528

Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial.

Mark B Powers1, Jasper A J Smits, Michael J Telch.   

Abstract

The primary aim of the current study was to further investigate the deleterious effects of safety-seeking behaviors on fear reduction by disentangling the effects of perceived availability of threat-relevant safety behaviors during treatment versus their actual use. Participants (N=72) displaying marked claustrophobic fear were randomly assigned to 1 of 5 conditions: (a) exposure only (EO), (b) exposure with phobic safety-behavior availability (SBA), (c) exposure with safety-behavior utilization (SBU), (d) credible placebo treatment (PL), or (e) wait list (WL). High end-state functioning rates at posttreatment were as follows: EO = 94%, SBA = 45%, SBU = 44%, PL = 25%, and WL = 0%. Findings suggest that it is the perception of the availability of safety aids as opposed to their actual use that exerts a disruptive effect on fear reduction. Clinical implications are discussed. (c) 2004 APA, all rights reserved

Entities:  

Mesh:

Year:  2004        PMID: 15279528     DOI: 10.1037/0022-006X.72.3.448

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  14 in total

1.  Prediction of "fear" acquisition in healthy control participants in a de novo fear-conditioning paradigm.

Authors:  Michael W Otto; Teresa M Leyro; Kelly Christian; Christen M Deveney; Hannah Reese; Mark H Pollack; Scott P Orr
Journal:  Behav Modif       Date:  2007-01

2.  The effects of safety behavior availability versus utilization on inhibitory learning during exposure.

Authors:  Joshua J Kemp; Shannon M Blakey; Kate B Wolitzky-Taylor; Jennifer T Sy; Brett J Deacon
Journal:  Cogn Behav Ther       Date:  2019-02-14

Review 3.  Threat reappraisal as a mediator of symptom change in cognitive-behavioral treatment of anxiety disorders: a systematic review.

Authors:  Jasper A J Smits; Kristin Julian; David Rosenfield; Mark B Powers
Journal:  J Consult Clin Psychol       Date:  2012-06-11

4.  Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes.

Authors:  Michael W Otto; R Kathryn McHugh; Kathleen M Kantak
Journal:  Clin Psychol (New York)       Date:  2010-06-08

5.  Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data.

Authors:  Mark B Powers; Johnna L Medina; Stephanie Burns; Brooke Y Kauffman; Marie Monfils; Gordon J G Asmundson; Allison Diamond; Christa McIntyre; Jasper A J Smits
Journal:  Cogn Behav Ther       Date:  2015-02-23

6.  The role of comorbidity in explaining the associations between anxiety disorders and smoking.

Authors:  Jesse R Cougle; Michael J Zvolensky; Kristin E Fitch; Natalie Sachs-Ericsson
Journal:  Nicotine Tob Res       Date:  2010-02-15       Impact factor: 4.244

Review 7.  Emotion regulation in youth with emotional disorders: implications for a unified treatment approach.

Authors:  Sarah E Trosper; Brian A Buzzella; Shannon M Bennett; Jill T Ehrenreich
Journal:  Clin Child Fam Psychol Rev       Date:  2009-09

8.  Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories.

Authors:  Marie-H Monfils; Kiriana K Cowansage; Eric Klann; Joseph E LeDoux
Journal:  Science       Date:  2009-04-02       Impact factor: 47.728

9.  Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia.

Authors:  Michael J Telch; Aleksandra K Bruchey; David Rosenfield; Adam R Cobb; Jasper Smits; Sandra Pahl; F Gonzalez-Lima
Journal:  Am J Psychiatry       Date:  2014-10       Impact factor: 18.112

Review 10.  Enhancing exposure-based therapy from a translational research perspective.

Authors:  Stefan G Hofmann
Journal:  Behav Res Ther       Date:  2007-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.